Ireland
--:--IST
Recruiting Observational

Cardiac Function in Swimming-Induced Pulmonary Edema (SIPE)

NCT05391737 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2022-07-06
Last updated
2026-10-05

Condition(s) studied

Swimming Induced Pulmonary Edema (SIPE)Pulmonary EdemaLung DiseasesHeart Function Tests

Investigational drug(s) / intervention(s)

EchocardiographyElectrocardiogram (ECG)Cardiac biomarkers

Echocardiography: Echocardiography after swimming (acute) and at rest (baseline)

Electrocardiogram (ECG): Electrocardiogram (ECG) after swimming (acute) and at rest (baseline)

Cardiac biomarkers: high sensitive (hs)-Troponin I and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) after swimming (acute) and at rest (baseline)

Study summary

Acute or chronic cardiac dysfunction could be a contributing factor to swimming-induced pulmonary edema (SIPE). Knowledge on cardiac function in SIPE is limited and recommendations for cardiac evaluation of patients with SIPE are lacking. The present study was designed to assess cardiac function in patients with SIPE and in asymptomatic swimmers.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: for patients: * respiratory symptoms during or after swimming at the Vansbrosimningen open water swimming event * diagnosis SIPE by signs of pulmonary edema on lung ultrasound * peripheral oxygen saturation ≤95% for controls: * completion of a swimming race of the Vansbrosimningen open water swimming event. * no respiratory symptoms during or after swimming * no signs of pulmonary edema on lung ultrasound * matched to patients with SIPE regarding sex and age Exclusion criteria: * declined consent * hemodynamic instability or decreased consciousness

Primary outcome measure(s)

  • Acute Echocardiography — within 4 hours after termination of swimming
    Transthoracic echocardiography with parasternal, apical and subcostal views. Including measurement of ventricular wall size, left ventricular strain, ejection fraction according to the modified Simpson method, diastolic function (using tissue doppler, mitral flow and pulmonary vein flow), right ventricular tricuspid annular plane systolic excursion (TAPSE), pressure gradient over the tricuspid valve, assessment of valve dysfunction, size and respiratory variation of the inferior vena cava, assessment of pericardial fluid.
  • Acute Electrocardiogram (ECG) - Rytm analysis — within 4 hours after termination of swimming
    12-lead electrocardiogram (ECG). Rytm analysis and frequency (beats per minute)
  • Acute Electrocardiogram (ECG) - Heart axis — within 4 hours after termination of swimming
    12-lead electrocardiogram (ECG). Assessment of QRS-axis (degrees)
  • Acute Electrocardiogram (ECG) - Amplitudes and intervals — within 4 hours after termination of swimming
    12-lead electrocardiogram (ECG). Duration of PQ-interval (ms), QRS-complex (ms), QT-interval (ms), QRS amplitude (mV)
  • Acute Electrocardiogram (ECG) - Signs of myocardial ischemia — within 4 hours after termination of swimming
    12-lead electrocardiogram (ECG). ST-elevation, ST-depression, T-wave inversion, Q wave.
  • Acute cardiac biomarkers - Troponin I — 4-6 hours after termination of swimming
    Venous samples. Measurement of hs-Troponin I (ng/L).
  • Acute cardiac biomarkers - NT-pro-BNP — 4-6 hours after termination of swimming
    Venous samples. Measurement of NT-pro-BNP (ng/L)

Trial sites (1)

FacilityCityRegionStatus
Center of Clinical Research Dalarna Falun Sweden Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05391737 on ClinicalTrials.gov ↗ ← All trials in Sweden